Evaluation and Therapy of Heart Disease in Patients Not Participating in Research (Teaching Protocol)
inpatient evaluation and management
Congenital Abnormalities+6
+ Cardiovascular Diseases
+ Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Summary
Study start date: January 1, 1995
Actual date on which the first participant was enrolled.There is an important need to maintain clinical skills, to ensure adequate training and expertise, and provide an environment that stimulates ideas for clinical research. This protocol permits inpatient evaluation and management of patients with heart disease who do not fulfill criteria for participation in existing Cardiology Branch research protocols.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Patients with signs or symptoms of heart disease. Patients selected because of either medical or research interest to the Principal Investigator. Patients must not have unstable angina pectoris, unstable course following recent (within one month) myocardial infarction. Must not be in New York Heart Association functional class IV heart failure. A positive pregnancy test will obviate any cardiovascular testing requiring ionizing radiation.
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, United StatesOpen National Heart, Lung and Blood Institute (NHLBI) in Google Maps